Questcor Pharmaceuticals Accounts Receivable:
59.28M for March 31, 2013Questcor Pharmaceuticals Historical Accounts Receivable Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 59.28M |
| Dec. 31, 2012 | 61.42M |
| Sept. 30, 2012 | 62.28M |
| June 30, 2012 | 46.67M |
| March 31, 2012 | 41.36M |
| Dec. 31, 2011 | 27.80M |
| Sept. 30, 2011 | 28.22M |
| June 30, 2011 | 23.71M |
| March 31, 2011 | 12.33M |
| Dec. 31, 2010 | 11.13M |
| Sept. 30, 2010 | 13.92M |
| June 30, 2010 | 11.93M |
| March 31, 2010 | 13.40M |
| Dec. 31, 2009 | 14.83M |
| Sept. 30, 2009 | 10.60M |
| June 30, 2009 | 12.04M |
| March 31, 2009 | 8.853M |
| Dec. 31, 2008 | 10.42M |
| Sept. 30, 2008 | 11.11M |
| June 30, 2008 | 21.59M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Accounts Receivable
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
YCharts takes accounts receivable from the balance sheet of a company. It is reported net of allowance for bad debts.
Learn More
QCOR Accounts Receivable Benchmarks
| Companies | |
|---|---|
| Theravance | 1.963M |
| Infinity Pharmaceuticals | |
| Synageva BioPharma | 2.599M |
QCOR Accounts Receivable Rankings
| Overall |
78th percentile 1739 of 8005 |
| Sector |
79th percentile 140 of 686 in Healthcare |
| Industry |
92nd percentile 18 of 248 in Biotechnology |
QCOR Accounts Receivable Range, Past 5 Years
| Minimum | 8.853M | Mar 2009 |
| Maximum | 62.28M | Sep 2012 |
| Average | 25.14M |
